Detalles de la búsqueda
1.
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE".
World J Urol
; 42(1): 169, 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492078
2.
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis.
Neoplasma
; 69(2): 404-411, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35014537
3.
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?
BJU Int
; 127(4): 454-462, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32969548
4.
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Eur Radiol
; 31(2): 716-728, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852590
5.
Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation.
Radiol Med
; 125(1): 107, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31591702
6.
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159).
BMC Cancer
; 19(1): 903, 2019 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500605
7.
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation.
Radiol Med
; 124(1): 65-78, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30219945
8.
Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform.
Acta Oncol
; 56(8): 1081-1088, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28534430
9.
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy.
BJU Int
; 114(6b): E3-E10, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24712723
10.
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?
Tumori
; 110(3): 193-202, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38726748
11.
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis.
Radiother Oncol
; 195: 110264, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561122
12.
Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
J Urol
; 189(6): 2099-103, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23313200
13.
Can Ki-67 predict radiotherapy response in neuroendocrine tumors? Retrospective analysis of a monocentric series of patients.
Tumori
; 109(5): 504-510, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36942401
14.
Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation Technique.
Curr Oncol
; 30(9): 7926-7935, 2023 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37754491
15.
Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series.
Cancers (Basel)
; 14(19)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230698
16.
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparison.
Tumori
; 108(3): 263-269, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33896239
17.
Physical and clinical implications of radiotherapy treatment of prostate cancer using a full bladder protocol.
Strahlenther Onkol
; 187(12): 799-805, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22127358
18.
Use of machine learning methods for prediction of acute toxicity in organs at risk following prostate radiotherapy.
Med Phys
; 38(6): 2859-67, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21815361
19.
Multidisciplinary team approach for Merkel cell carcinoma: the European Institute of Oncology experience with focus on radiotherapy.
Tumori
; 107(2): 145-149, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32734835
20.
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience.
Phys Med
; 92: 62-68, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871888